To determine their impacts on adipocyte exosome-mediated MM drug resistance, we used specific shRNAs targeting LOC606724 or SNHG1 to knock down their expression in MMADs and found reduced levels of exosomal LOC606724 or SNHG1 (Fig. 3g). The gene discussed is SNHG1; the disease is Miyoshi myopathy.